Do you want to read an article? Please log in or register.
Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
Migraine and Headache
RECOMMENDED
Related content
Migraine and Headache
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis
Cephalalgia
Drellia K, Kokoti L, Deligianni CI, Papadopoulos D, Mitsikostas DD
doi: 10.1177/0333102421989601
RECOMMENDED
Migraine and Headache
Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review
Headache.
Yuan H, Spare NM, Silberstein SD
doi: 10.1111/head.13583.
RECOMMENDED
Migraine and Headache
Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial
Brain.
Pijpers JA, Kies DA, Louter MA, van Zwet EW, Ferrari MD, Terwindt GM
doi: 10.1093/
COMMENTED
Migraine and Headache
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
Cephalalgia.
Buse DC, Lipton RB, Hallström Y, Reuter U, Tepper SJ, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA
doi: 10.1177/0333102418789072.
RECOMMENDED
Migraine and Headache
Systematic Review: Acupuncture vs Standard Pharmacological Therapy for Migraine Prevention
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Headache.
Zhang N, Houle T, Hindiyeh N, Aurora SK
doi: 10.1111/head.13723.
Migraine and Headache
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study
Cephalalgia
Gantenbein AR, Agosti R, Gobbi C, Flügel D, Schankin CJ, Viceic D, Zecca C, Pohl H
doi: 10.1177/03331024211014616
Migraine and Headache
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study
Cephalalgia
Overeem LH, Peikert A, Hofacker MD, Kamm K, Ruscheweyh R, Gendolla A, Raffaelli B, Reuter U, Neeb L
doi: 10.1177/03331024211048765
Migraine and Headache
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study
Cephalalgia
Raffaelli B, Terhart M, Overeem LH, Mecklenburg J, Neeb L, Steinicke M, Reuter U
doi: 10.1177/03331024211046617
Migraine and Headache
Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class
Headache.
Hargreaves R, Olesen J
doi: 10.1111/head.13510.